Regulatory News
Wednesday, May 11, 2016
BRIEF-Biofrontera expects commercial launch of Ameluz and BF-RhodoLED in US by September 2016
* Expects commercial launch of Ameluz and BF-RhodoLED in
U.S. by September 2016
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment